The RPL38 antibody is a polyclonal immunoglobulin (IgG) used in molecular biology research to detect the ribosomal protein L38 (RPL38), a critical component of the 60S ribosomal subunit. RPL38 plays a central role in ribosome biogenesis, protein synthesis, and cellular growth regulation. This antibody is widely employed in techniques such as Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) to study RPL38 expression and its implications in disease states .
RPL38 is an 8 kDa protein localized to the cytoplasm, cytosol, and ribosomes. It facilitates ribosome assembly and protein translation, with emerging evidence linking its dysregulation to cancer progression and autoimmune disorders . The antibody targets a recombinant fusion protein corresponding to amino acids 1–70 of human RPL38 (NP_000990.1), ensuring high specificity for human, mouse, and rat samples .
RPL38 is overexpressed in various cancers, including breast and colon tumors, making it a potential biomarker . Studies using RPL38 antibodies have demonstrated its utility in:
Ribosome dynamics: Investigating how RPL38 modulates translation efficiency in tumor cells .
Therapeutic targeting: Monoclonal antibodies (e.g., trastuzumab) leverage RPL38 as a surrogate marker for ribosomal activity in targeted therapies .
Autoantibodies to RPL38-derived epitopes (e.g., aa 229–243) are associated with systemic sclerosis (SSc). A 2019 study found that detecting these autoantibodies improves SSc diagnosis sensitivity, highlighting RPL38’s role in autoimmune pathogenesis .
RPL38 antibodies have been used to study ribosomal dysfunction in neurodegenerative diseases, including Alzheimer’s disease, where altered ribosome biogenesis correlates with amyloid precursor protein metabolism .
RPL38 functions as a component of the large ribosomal subunit within the ribonucleoprotein complex responsible for cellular protein synthesis. Its significance extends beyond structural roles, as RPL38 has been implicated in selective translation of specific mRNAs, particularly Hox mRNAs crucial for vertebrate development . The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell . Research into RPL38 provides valuable insights into ribosomal biogenesis, translational regulation, and developmental processes, making it an important target for developmental biology and cancer research.
RPL38 antibodies serve multiple research applications, with validated uses including:
The choice of application should align with specific research objectives and experimental design requirements .
Proper validation ensures experimental reliability and reproducibility. Recommended validation approaches include:
Genetic validation: Testing in RPL38 knockout/knockdown models (using CRISPR-Cas9, siRNA) to confirm signal loss
Positive controls: Using cell lines with known RPL38 expression (e.g., HeLa cells as demonstrated in the literature)
Technical controls: Including secondary-antibody-only controls to detect non-specific binding
Cross-technique validation: Confirming consistent results across multiple detection methods
Peptide competition: Pre-incubating the antibody with immunizing peptide to block specific binding
For polyclonal antibodies like the rabbit polyclonal anti-RPL38 (ab236880), batch-to-batch variation should be considered when planning long-term studies .
Optimization is essential for obtaining reliable and reproducible results across different experimental systems:
Western Blot Optimization:
Start with manufacturer-recommended dilution (e.g., 1:1000 for ab236880)
Perform titration experiments with different antibody concentrations
For whole cell lysates (e.g., EC109), ensure complete protein extraction using appropriate lysis buffers
Verify transfer efficiency, especially for low molecular weight proteins like RPL38 (~8 kDa)
Immunofluorescence Optimization:
Test multiple fixation methods (paraformaldehyde vs. methanol)
Optimize permeabilization conditions to ensure antibody access to nuclear/nucleolar compartments
Consider antigen retrieval methods for tissue sections
Select appropriate secondary antibodies (e.g., Alexa-Fluor®488-conjugated Goat Anti-Rabbit IgG)
Systematic optimization should include documentation of all variables and include appropriate controls in each experiment.
RPL38's dynamic localization provides insights into ribosome biogenesis and function:
Advanced imaging approaches, such as confocal microscopy with Z-stack analysis, can differentiate between these compartments. The observed dual localization of RPL38 in both nuclear and cytoplasmic compartments reflects its role in ribosome biogenesis and function .
Inconsistent results often stem from multiple sources. A systematic approach includes:
Sample Preparation Issues:
Ensure complete lysis for protein extraction (particularly important for nuclear proteins)
Use fresh samples with appropriate protease inhibitors
Standardize sample collection and processing
Antibody-Related Factors:
Avoid repeated freeze-thaw cycles of antibody aliquots
Verify antibody storage conditions (-20°C for long-term storage)
Test different lot numbers if inconsistencies persist
Technical Variables:
For Western blotting: Optimize transfer conditions for small proteins (~8 kDa)
For ICC/IF: Test different fixation and permeabilization methods
Standardize incubation times and temperatures
When troubleshooting, change only one variable at a time and document all conditions systematically to identify the source of inconsistency.
RPL38 has specialized roles in translational control, particularly for specific mRNAs:
Experimental Approaches:
Combine RPL38 immunoprecipitation with RNA sequencing to identify associated transcripts
Use proximity labeling techniques (BioID, APEX) with RPL38 antibodies to identify interaction partners
Perform polysome profiling with RPL38 antibody detection to examine its association with actively translating ribosomes
Correlate RPL38 levels with translation of specific mRNAs using reporter assays
These approaches can reveal how RPL38 contributes to specialized translation functions beyond its structural role in the ribosome.
Post-translational modifications (PTMs) can significantly impact antibody recognition:
| Modification Type | Potential Effect on Antibody Recognition | Experimental Approach |
|---|---|---|
| Phosphorylation | May mask epitope or create conformational changes | Compare detection before/after phosphatase treatment |
| Ubiquitination | Can affect protein stability and detection | Use proteasome inhibitors to stabilize modified forms |
| Acetylation | May alter epitope accessibility | Compare detection in presence/absence of deacetylase inhibitors |
| Protein-protein interactions | Can occlude antibody binding sites | Use different lysis conditions to disrupt interactions |
Researchers should be aware that detection patterns may vary under different cellular conditions that affect RPL38 modifications.
The evolutionary conservation of RPL38 affects antibody applications across species:
Key Considerations:
Epitope conservation: Compare the immunogen sequence with target species
Validation status: Check if the antibody is validated in your species of interest
Appropriate controls: Include samples from species with known reactivity
Cross-reactivity testing: Perform preliminary validation in new species
Conventional microscopy may not fully resolve the detailed localization of RPL38 within subcellular compartments. Super-resolution approaches offer significant advantages:
| Technique | Resolution | Advantages for RPL38 Studies |
|---|---|---|
| STED microscopy | ~50nm | Resolves nucleolar subcompartments where RPL38 localizes |
| STORM/PALM | ~20nm | Can distinguish individual ribosomes |
| SIM | ~100nm | Good for live-cell imaging of RPL38 dynamics |
| Expansion microscopy | ~70nm | Works with standard confocal microscopes |
For optimal results with super-resolution techniques, antibody specificity becomes even more critical, and specialized sample preparation protocols may be necessary.
Multiplexed detection provides context for RPL38 function within the ribosomal machinery:
Effective Multiplexing Approaches:
Sequential immunostaining with RPL38 and other ribosomal proteins
Multi-color immunofluorescence combining RPL38 with nucleolar markers
Proximity ligation assays (PLA) to detect interactions between RPL38 and other proteins
Combined immunofluorescence and RNA FISH to correlate RPL38 localization with specific mRNAs
When designing multiplexed experiments, consider antibody species compatibility, fluorophore selection to minimize spectral overlap, and appropriate controls for each marker.
Modern image analysis tools can extract quantitative data from RPL38 immunostaining:
Quantitative Approaches:
Measure relative intensity of RPL38 staining across different cellular compartments
Track dynamic changes in RPL38 localization during cell cycle or stress responses
Analyze co-localization coefficients between RPL38 and other markers
Perform single-particle tracking in live cells with fluorescently tagged RPL38
These quantitative approaches transform descriptive observations into measurable parameters that can be statistically analyzed.